AstraZeneca Pharma posted a 45.7% fall in net profit to Rs 11.42 crore in Q3 FY22 from Rs 21.05 crore posted in Q3 FY21.
SGX Nifty: Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could rise 79 points at the opening bell. Meanwhile, the Reserve Bank of India (RBI)s rate-setting Monetary Policy Committee (MPC) meeting commenced on 8 February 2022 and the outcome would be announced on 10 February 2022. The RBI may hold its repo rate steady but an increase in […]
The US stock market recouped early losses to finish session notably higher on Tuesday, 08 February 2022, on the back of strength in materials, consumer discretionary, financials, and information technology stocks, while losses in energy and realty stocks capped upside. At the close of trade, the Dow Jones Industrial Average index rose 371.65 points, or 1.06%, to 35,462.78. The S&P500 index was up 37.67 points, […]
Sales decline 37.70% to Rs 73.86 crore
Sales rise 126.45% to Rs 42.12 crore
Sales decline 82.74% to Rs 12.43 crore
Sales rise 72.92% to Rs 37.61 crore
Sales rise 11.63% to Rs 219.26 crore
Sales rise 37.42% to Rs 1023.62 crore
Total Operating Income decline 2.73% to Rs 2019.77 crore

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.